XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Deficit) (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity under the Plans

Stock option activity under the Plans for the nine months ended September 30, 2022 was as follows:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value

 

Balance—December 31, 2021

 

 

23,000,872

 

 

$

5.62

 

 

 

6.81

 

 

$

436,630

 

Granted

 

 

155,764

 

 

 

11.62

 

 

 

 

 

 

 

Exercised

 

 

(3,509,007

)

 

 

4.05

 

 

 

 

 

 

 

Canceled

 

 

(832,610

)

 

 

7.20

 

 

 

 

 

 

 

Balance—September 30, 2022

 

 

18,815,019

 

 

$

5.89

 

 

 

6.11

 

 

$

109,247

 

Options vested

 

 

13,714,778

 

 

$

3.99

 

 

 

5.49

 

 

$

94,689

 

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

RSU activity for the nine months ended September 30, 2022 was as follows:

 

 

 

Number of
Shares

 

 

Weighted-Average
Grant Fair Value

 

 

Aggregate
Intrinsic
Value

 

Unvested balance—December 31, 2021

 

 

7,387,288

 

 

$

29.68

 

 

$

180,545

 

Granted

 

 

14,312,180

 

 

 

15.03

 

 

 

 

Vested

 

 

(1,094,522

)

 

 

30.17

 

 

 

 

Forfeited

 

 

(1,082,838

)

 

 

28.53

 

 

 

 

Unvested balance—September 30, 2022

 

 

19,522,108

 

 

$

18.97

 

 

$

210,448

 

Summary of Stock-Based Compensation Expense in the Consolidated Statements of Operations

Stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021 is classified in the unaudited condensed consolidated statements of operations as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cost of revenue

 

$

683

 

 

$

527

 

 

$

2,072

 

 

$

1,537

 

Research and development

 

 

11,675

 

 

 

11,259

 

 

 

34,037

 

 

 

31,650

 

Sales and marketing

 

 

7,630

 

 

 

6,846

 

 

 

21,952

 

 

 

19,504

 

General and administrative

 

 

6,382

 

 

 

4,776

 

 

 

17,792

 

 

 

15,176

 

Total

 

$

26,370

 

 

$

23,408

 

 

$

75,853

 

 

$

67,867

 

Summary of Shares of Common Stock Reserved for Future Issuance The Company’s common stock reserved for future issuance was as follows:

 

 

 

September 30, 2022

 

 

December 31, 2021

 

Stock options outstanding

 

 

18,815,019

 

 

 

23,000,872

 

RSUs outstanding

 

 

19,522,108

 

 

 

7,387,288

 

Shares available for future grants

 

 

12,918,346

 

 

 

16,905,525

 

Total shares of common stock reserved

 

 

51,255,473

 

 

 

47,293,685